Abstract
The Growth Arrest and DNA Damage-inducible 45 (GADD45) proteins have been implicated in regulation of many cellular functions including DNA repair, cell cycle control, senescence and genotoxic stress. However, the pro-apoptotic activities have also positioned GADD45 as an essential player in oncogenesis. Emerging functional evidence implies that GADD45 proteins serve as tumor suppressors in response to diverse stimuli, connecting multiple cell signaling modules. Defects in the GADD45 pathway can be related to the initiation and progression of malignancies. Moreover, induction of GADD45 expression is an essential step for mediating anti-cancer activity of multiple chemotherapeutic drugs and the absence of GADD45 might abrogate their effects in cancer cells. In this review, we present a comprehensive discussion of the functions of GADD45 proteins, linking their regulation to effectors of cell cycle arrest, DNA repair and apoptosis. The ramifications regarding their roles as essential and central players in tumor growth suppression are also examined. We also extensively review recent literature to clarify how different chemotherapeutic drugs induce GADD45 gene expression and how its up-regulation and interaction with different molecular partners may benefit cancer chemotherapy and facilitate novel drug discovery.
Keywords: Apoptosis, cancer, GADD45 family, survival.
Current Molecular Medicine
Title:GADD45 Proteins: Central Players in Tumorigenesis
Volume: 12 Issue: 5
Author(s): R. E. Tamura, J. F. de Vasconcellos, D. Sarkar, T. A. Libermann, P. B. Fisher and L. F. Zerbini
Affiliation:
Keywords: Apoptosis, cancer, GADD45 family, survival.
Abstract: The Growth Arrest and DNA Damage-inducible 45 (GADD45) proteins have been implicated in regulation of many cellular functions including DNA repair, cell cycle control, senescence and genotoxic stress. However, the pro-apoptotic activities have also positioned GADD45 as an essential player in oncogenesis. Emerging functional evidence implies that GADD45 proteins serve as tumor suppressors in response to diverse stimuli, connecting multiple cell signaling modules. Defects in the GADD45 pathway can be related to the initiation and progression of malignancies. Moreover, induction of GADD45 expression is an essential step for mediating anti-cancer activity of multiple chemotherapeutic drugs and the absence of GADD45 might abrogate their effects in cancer cells. In this review, we present a comprehensive discussion of the functions of GADD45 proteins, linking their regulation to effectors of cell cycle arrest, DNA repair and apoptosis. The ramifications regarding their roles as essential and central players in tumor growth suppression are also examined. We also extensively review recent literature to clarify how different chemotherapeutic drugs induce GADD45 gene expression and how its up-regulation and interaction with different molecular partners may benefit cancer chemotherapy and facilitate novel drug discovery.
Export Options
About this article
Cite this article as:
E. Tamura R., F. de Vasconcellos J., Sarkar D., A. Libermann T., B. Fisher P. and F. Zerbini L., GADD45 Proteins: Central Players in Tumorigenesis, Current Molecular Medicine 2012; 12 (5) . https://dx.doi.org/10.2174/156652412800619978
DOI https://dx.doi.org/10.2174/156652412800619978 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Omega-3 Polyunsaturated Fatty Acids in Alzheimers Disease: Key Questions and Partial Answers
Current Alzheimer Research Autoimmune Pancreatitis and Diagnostic Criteria
Current Immunology Reviews (Discontinued) Evaluation of Activity Kinetic Parameters of SK319cys, As a New Cysteine Variant of Streptokinase: A Comparative Study
Current Pharmaceutical Biotechnology Personal Genetics – Sports Utility Vehicle?
Recent Patents on DNA & Gene Sequences Idiotype Vaccines for Human B-Cell Malignancies
Current Pharmaceutical Design An Updated Review on Complicated Mechanisms of COVID-19 Pathogenesis and Therapy: Direct Viral Damage, Renin-angiotensin System Dysregulation, Immune System Derangements, and Endothelial Dysfunction
Infectious Disorders - Drug Targets Microarray Analysis Reveals CCL24/Eotaxin-2 as an Effector of the Pathogenetic Effects Induced by HIV-1 Nef
Current Drug Discovery Technologies Variety of Interpretation Systems for Human Immunodeficiency Virus Type 1 Genotyping: Confirmatory Information or Additional Confusion?
Current Drug Targets - Infectious Disorders Adult Hippocampal Neurogenesis, Aging and Neurodegenerative Diseases: Possible Strategies to Prevent Cognitive Impairment
Current Topics in Medicinal Chemistry Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
Current Nanomedicine Anti-inflammatory Property of AMP-activated Protein Kinase
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry HIVs Evasion of Hosts NK Cell Response and Novel Ways of its Countering and Boosting Anti-HIV Immunity
Current HIV Research Polymyxin-B Endotoxin Removal Device: Making the Point on Mechanisms of Action, Clinical Effectiveness and Possible Future Applications: Review
Infectious Disorders - Drug Targets Cannabinoids: Occurrence and Medicinal Chemistry
Current Medicinal Chemistry Systems Biology: Understanding Function from Genes to Networks
Current Proteomics Pentoxifylline Use in Dermatology
Inflammation & Allergy - Drug Targets (Discontinued) The Effect of Dexamethasone on Lipopolysaccharide-induced Inflammation of Endothelial Cells of the Blood-brain Barrier/Brain Capillaries
Current Neurovascular Research The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis
Current Drug Discovery Technologies Enhancement of Solubility and Permeability of Candesartan Cilexetil by Using Different Pharmaceutical Interventions
Current Drug Delivery Modified LDL Immune Complexes and Cardiovascular Disease
Current Medicinal Chemistry